Cancers in Different Conditions, Cancer Research Methods and Diagnosis: An Interdisciplinary Approach

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.

• Cancer in Patients with Autism Spectrum Disorder: Risk and Challenges.- What is the Relationship between Cancer and Alzheimer’s Disease? Different and Similar Mechanisms between the Two Diseases.- The Evolving Role of Transplant Oncology.- The Role of Geriatric Assessment in the Older Person with Cancer.- Carcinogenesis Mechanisms in Inborn Errors of Immunity.- Virus-related Lymphoproliferation and Cancer Development in Inborn Errors of Immunity.- Celiac Disease and Digestive Malignancies.- Diabetes Mellitus and the Risk Of Carcinogenesis: an Interdisciplinary Approach.- Patient-Derived Organoids: Past, Present and Future.- Embodied Research Methods: The Empiricism of Lived Experiences to Advance Health Equity.- Cancer and obesity: Crosstalk Between Adipocytes and Cancer Cells in the Tumor Microenvironment as a New Target in Cancer Research.- Exploring Current In Vitro Models for Cancer Research.- Exercise and Energy Metabolism in Cancer Research.- Metabolomics and Cancer: Identification of Biomarkers from Plant-based Pharmaceuticals Using an Integrated Approach.- Advances in Biomedical Imaging Modalities for Cancer Research and Diagnostics.- Targeted Alpha Therapy in Cancer Management: Therapeutic Prospects of Nuclear Medicine in Oncology.- Beyond FDG: FAPI Role in Cancer Imaging.- c-Met receptor PET Imaging Probes for Cancer Detection and Monitoring.- Instruments for the Evaluation of Symptoms in Cancer Patients.- Carbon Dots in Cancer Detection and Therapy.- Biomaterials and Nanomedicines: Progress in Cancer Research.- Multi-Targeting Compounds in Cancer Research.- The Predictive Power of Biomarkers in Osteoradionecrosis.- Fibrolamellar Carcinoma: A distinct Variant of Hepatocellular Carcinoma.- Drug Repositioning Using Single-Cell RNA-Sequencing in Cancer Research.- Molecular Docking and In Vitro Studies of Anti-colon Cancer Activities of Piper betle Mediated by Increased Apoptosis via PI3-K Pathways.